Collectively, our data suggests that eliminating the deleterious effects of TXA2R signaling along this pathway should significantly improve patient outcomes with respect to ventricular arrhythmias and cardiac remodeling. The gene discussed is TBXA2R; the disease is Ventricular arrhythmia.